Introduction Trintellix is the brand name of vortioxetine, an oral antidepressant used for the treatment of major depressive disorder in adults. It is commonly described as a multimodal serotonergic antidepressant because it affects serotonin reuptake and multiple serotonin receptor subtypes. Current prescribing information lists Trintellix as indicated for major depressive disorder in adults. Trintellix is … Read more
Introduction Qelbree is the brand name of viloxazine extended-release, a non-stimulant drug used for the treatment of attention-deficit/hyperactivity disorder, commonly called ADHD. It is indicated for ADHD in adults and pediatric patients 6 years of age and older. Qelbree is pharmacologically important because it is different from stimulant ADHD medicines such as methylphenidate and amphetamine … Read more
Introduction Zeposia is the brand name of ozanimod, an oral immunomodulatory drug used mainly in relapsing forms of multiple sclerosis and moderately to severely active ulcerative colitis. It belongs to the class of sphingosine-1-phosphate receptor modulators, commonly called S1P receptor modulators. Zeposia is important in pharmacology because it does not act like a conventional anti-inflammatory … Read more
Introduction Zolpidem is a non-benzodiazepine sedative-hypnotic drug primarily used for the short-term treatment of insomnia. It belongs to a class of medications commonly referred to as “Z-drugs,” which also includes zaleplon and zopiclone/eszopiclone. Although structurally different from benzodiazepines, zolpidem exerts its pharmacological effects through the gamma-aminobutyric acid (GABA) neurotransmitter system. Zolpidem is particularly effective in … Read more
Introduction Atomoxetine is a selective norepinephrine reuptake inhibitor (NRI) approved for the treatment of Attention-Deficit/Hyperactivity Disorder (ADHD). It is a non-stimulant alternative to conventional stimulants like methylphenidate and amphetamines, especially beneficial for patients at risk of substance abuse or with contraindications to stimulants. Mechanism of Action (Stepwise) Pharmacokinetics Clinical Uses Adverse Effects Comparative Analysis Feature … Read more
Introduction Strattera, the brand name for atomoxetine, is a non-stimulant medication used primarily in the treatment of attention-deficit hyperactivity disorder (ADHD). Unlike stimulant medications such as methylphenidate or amphetamines, atomoxetine works through selective modulation of norepinephrine. Mechanism of Action (Stepwise Points) Pharmacokinetics Clinical Uses Adverse Effects Comparative Analysis Feature Atomoxetine (Strattera) Methylphenidate Amphetamine Drug Class … Read more
Introduction Levetiracetam is a widely used antiepileptic drug (AED) known for its unique mechanism of action, high tolerability, and minimal drug interactions. It is indicated in the treatment of various seizure types and is favored in both pediatric and adult populations. Mechanism of Action (Stepwise Points) Pharmacokinetics Clinical Uses Adverse Effects Comparative Analysis Feature Levetiracetam … Read more
Introduction Tetrabenazine is a centrally acting vesicular monoamine transporter 2 (VMAT2) inhibitor used primarily to manage hyperkinetic movement disorders. It is especially effective in reducing chorea associated with Huntington’s disease. By depleting monoamines such as dopamine from nerve terminals, it helps in restoring neurochemical balance in the basal ganglia. Mechanism of Action (Stepwise Points) Pharmacokinetics … Read more
